- Home
- / GeneOne Life Science
GeneOne Life Science
Stock Price
₩2.3 K
2024-10-29
Market Capitalization
₩204.4 B
2024-10-29
Revenue
₩40.2 B
FY, 2023
GeneOne Life Science Summary
Company Summary
- Overview
- GeneOne Life Science (진원생명과학) is a biopharmaceutical research and development company. It is dedicated to the development and contract manufacturing of gene-based-biomedicines, including DNA vaccines, DNA-based protein drugs, DNA-based monoclonal antibody drugs, mRNA vaccines, and RNA therapeutics.
- Type
- Public
- Status
- Active
- Founded
- 1976
- Website
- http://www.genels.com/
- Cybersecurity rating
- ESG rating
Table of Contents
GeneOne Life Science Financials
Summary Financials
- Revenue (Q3, 2025)
- ₩5.1B
- Gross profit (Q3, 2025)
- (₩414.7M)
- Net income (Q3, 2025)
- (₩11.5B)
- Cash (Q3, 2025)
- ₩985.9M
- EBIT (Q3, 2025)
- (₩10.9B)
- Enterprise value
- $233.8B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026